antimycin a has been researched along with tacrolimus in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Morin, C; Simon, N; Thiault, L; Tillement, JP; Zini, R | 1 |
| Bauer, BE; Chen, XJ; Clark-Walker, GD; Kuchler, K | 1 |
| Castilho, RF; Kowaltowski, AJ; Maciel, EN; Rodrigues, JM; Schwalm, FD; Souza, DO; Vercesi, AE; Wajner, M | 1 |
| Andreka, P; Bishopric, NH; Evans, WH; Haywood, GA; Martin, PE; Turner, MS; Webster, KA; You, L | 1 |
| Hur, KY; Kim, J; Lee, MS; Oh, GT; Park, K; Seo, S; Sonn, SK | 1 |
7 other study(ies) available for antimycin a and tacrolimus
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Tacrolimus decreases in vitro oxidative phosphorylation of mitochondria from rat forebrain.
Topics: Adenosine Triphosphate; Animals; Antimycin A; Cerebral Cortex; Dose-Response Relationship, Drug; Enzyme Inhibitors; Immunosuppressive Agents; In Vitro Techniques; Male; Methacrylates; Mitochondria; Multienzyme Complexes; Oxidative Phosphorylation; Oxygen Consumption; Proton-Translocating ATPases; Rats; Rats, Wistar; Tacrolimus; Thiazoles | 1998 |
Positive and negative control of multidrug resistance by the Sit4 protein phosphatase in Kluyveromyces lactis.
Topics: 4-Nitroquinoline-1-oxide; Antifungal Agents; Antimycin A; Drug Resistance, Multiple; Econazole; Genetic Complementation Test; Genotype; Ketoconazole; Kluyveromyces; Molecular Sequence Data; Oligomycins; Paromomycin; Phosphoprotein Phosphatases; Protein Phosphatase 2; Restriction Mapping; Saccharomyces cerevisiae Proteins; Sorbic Acid; Tacrolimus | 2000 |
Mitochondrial permeability transition in neuronal damage promoted by Ca2+ and respiratory chain complex II inhibition.
Topics: Animals; Antimycin A; Bongkrekic Acid; Brain; Calcimycin; Calcium; Catalase; Cell Survival; Cyclosporins; Dose-Response Relationship, Drug; Drug Interactions; Electron Transport Complex II; Enzyme Inhibitors; Female; In Vitro Techniques; Ionophores; Malonates; Membrane Potentials; Methylmalonic Acid; Mitochondria; NADP; Neurons; Nitro Compounds; Oxygen Consumption; PC12 Cells; Permeability; Propionates; Rats; Rotenone; Tacrolimus; Tetrazolium Salts; Thiazoles; Uncoupling Agents | 2004 |
Reversible connexin 43 dephosphorylation during hypoxia and reoxygenation is linked to cellular ATP levels.
Topics: Adenosine Triphosphate; Alkaloids; Aminoimidazole Carboxamide; Animals; Antimycin A; Benzophenanthridines; Brefeldin A; Carbazoles; Cell Hypoxia; Cells, Cultured; Connexin 43; Cycloheximide; Deoxyglucose; Flavonoids; Imidazoles; Indoles; JNK Mitogen-Activated Protein Kinases; Maleimides; Myocardial Contraction; Myocytes, Cardiac; Okadaic Acid; Ouabain; Phenanthridines; Phosphorylation; Potassium Cyanide; Protein Processing, Post-Translational; Pyridines; Pyrroles; Rats; Recombinant Fusion Proteins; Ribonucleotides; Staurosporine; Tacrolimus; Tetradecanoylphorbol Acetate | 2004 |
Impaired TFEB activation and mitophagy as a cause of PPP3/calcineurin inhibitor-induced pancreatic β-cell dysfunction.
Topics: Antimycin A; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Calcineurin Inhibitors; Glucose Intolerance; Humans; Insulins; Lysosomes; Mitophagy; Oligomycins; Rotenone; Tacrolimus | 2023 |